Science Explorer Back to mapMap

Most cited papers from Anthera Pharmaceuticals (United States)

What are the most cited papers from Anthera Pharmaceuticals (United States)?

The most cited paper from Anthera Pharmaceuticals (United States) is "EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS" (Lloyd Paul Aiello, Alexander J. Brucker, Stanley Chang et al., 2004), with 413 citations. Next come "A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study" (170) and "Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial" (161).

Showing 50 of 76 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS Lloyd Paul Aiello, Alexander J. Brucker, Stanley Chang et al. · Retina Oct 2004 413
2 A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study Richard Alan Furie, Gastón P. León, Meenu Thomas et al. · Annals of the Rheumatic Diseases 20 Apr 2014 170
3 Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial Joan T. Merrill, William R Shanahan, Morton Aaron Scheinberg et al. · Annals of the Rheumatic Diseases Open access Jun 2018 161
4 Fomivirsen Richard S. Geary, Scott P. Henry, Lisa R. Grillone · Clinical Pharmacokinetics 2002 159
5 Characterization of pulmonary function in Duchenne Muscular Dystrophy Oscar Henry Mayer, Richard S. Finkel, Christian Rummey et al. · Pediatric Pulmonology Open access 9 Mar 2015 156
6 Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial Robert S. Rosenson, Colin Hislop, Daniel S McConnell et al. · The Lancet Feb 2009 114
7 Tachykinins activate guinea‐pig alveolar macrophages: involvement of NK2 and NK1 receptors Sandra Brunelleschi, L. Vanni, Fabrizio Ledda et al. · British Journal of Pharmacology Open access Jul 1990 107
8 Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients Robert S. Rosenson, Colin Hislop, Michael D. Elliott et al. · Journal of the American College of Cardiology Open access Sep 2010 100
9 Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and Inflammation Eric D. Donnenfeld, Edward J. Holland, Robert H. Stewart et al. · Ophthalmology 20 Apr 2007 88
10 Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE− / − Mice Heather I. Fraser, Colin Hislop, Robert Christie et al. · Journal of Cardiovascular Pharmacology 2009 88
11 Further evidence for the existence of NK2 tachykinin receptor subtypes Riccardo Patacchini, Mara Astolfi, Laura Quartara et al. · British Journal of Pharmacology Open access Sep 1991 77
12 A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy Rony Chidiac, Md. Joynal Abedin, Graham Dickson and Hugh MacLeod et al. · EMBO Molecular Medicine Open access 9 Jun 2021 74
13 Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease Robert S. Rosenson, Michael D. Elliott, Yuri Stasiv et al. · European Heart Journal 16 Nov 2010 67
14 Potent contractile activity of endothelin on the human isolated urinary bladder Carlo Alberto Maggi, Sandro Giuliani, Riccardo Patacchini et al. · British Journal of Pharmacology Open access Apr 1989 66
15 The synergistic inhibition of atherogenesis in apoE−/− mice between pravastatin and the sPLA2 inhibitor varespladib (A-002) Zory Shaposhnik, Xuping Wang, Joaquim Trias et al. · Journal of Lipid Research Open access 22 Nov 2008 64
16 Multiple sources of calcium for contraction of the human urinary bladder muscle Carlo Alberto Maggi, Sandro Giuliani, Riccardo Patacchini et al. · British Journal of Pharmacology Open access Nov 1989 54
17 Effect of calpain and proteasome inhibition on Ca 2+ ‐dependent proteolysis and muscle histopathology in the mdx mouse Alexandre Briguet, Michael A. Erb, I. Courdier-Fruh et al. · The FASEB Journal 26 Aug 2008 53
18 Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial William R Shanahan, Jed E. Rose, Alan Glicklich et al. · Nicotine & Tobacco Research 2 Nov 2016 51
19 Barriers to drug adherence in the treatment of urea cycle disorders: Assessment of patient, caregiver and provider perspectives Oleg A. Shchelochkov, Klara Dickinson, Bruce F. Scharschmidt et al. · Molecular Genetics and Metabolism Reports Open access 21 Jul 2016 49
20 The presence of mucosa reduces the contractile response of the guinea-pig urinary bladder to substance P Carlo Alberto Maggi, Paolo Santicioli, Massimo Parlani et al. · Journal of Pharmacy and Pharmacology Aug 1987 49
21 Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children Mark B. Abelson, Gail L. Torkildsen, Jon I. Williams et al. · Clinical Therapeutics Sep 2009 48
22 Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial Stephen James Nicholls, Matthew Aaron Cavender, John J.P. Kastelein et al. · Cardiovascular Drugs and Therapy Open access 23 Nov 2011 45
23 A-002 (Varespladib), a phospholipase A2inhibitor, reduces atherosclerosis in guinea pigs José Oyama Moura Leite, Ushma Vaishnav, Michael J. Puglisi et al. · BMC Cardiovascular Disorders Open access 17 Feb 2009 42
24 Outcomes After Metal-on-metal Hip Revision Surgery Depend on the Reason for Failure: A Propensity Score-matched Study Gulraj S. Matharu, Andrew Judge, David W. Murray et al. · Clinical Orthopaedics and Related Research Open access 17 Jan 2018 40
25 Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod Michelle Petri, Renée S. Martin, Morton Aaron Scheinberg et al. · Lupus 28 Jun 2016 40
26 Influence of peripherally-administered peptides on ethanol-induced gastric ulcers in the rat Stefano Evangelista, Carlo Alberto Maggi, Alberto Meli · General Pharmacology The Vascular System 1987 38
27 Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate Jon I. Williams, James A. Gow, Sharon M. Klier et al. · Current Medical Research and Opinion 25 Aug 2010 34
28 Pupil dilatation in response to vagal afferent electrical stimulation is mediated by inhibition of parasympathetic outflow in the rat Ralph Bianca, Barry R. Komisaruk · Brain Research 14 Aug 2007 34
29 Safety and Efficacy of Bromfenac Ophthalmic Solution (Bromday) Dosed Once Daily for Postoperative Ocular Inflammation and Pain Bonnie An Henderson, Johnny L. Gayton, Simon P. Chandler et al. · Ophthalmology 23 Jul 2011 33
30 Varespladib Inhibits Secretory Phospholipase A2 in Bronchoalveolar Lavage of Different Types of Neonatal Lung Injury Danièle De Luca, Angelo Minucci, Joaquim Trias et al. · The Journal of Clinical Pharmacology 21 May 2011 33
31 The reversed binding of β-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors Sonja Nordhoff, Silvia Cerezo-Gálvez, Achim Feurer et al. · Bioorganic & Medicinal Chemistry Letters Open access 12 Jan 2006 32
32 Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain Steven Silverstein, Melissa G. Cable, Ehsan Sadri et al. · Current Medical Research and Opinion 14 Jul 2011 29
33 An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine Judy Caron, Randall E. Kaye, Thomas C. Wessel et al. · Journal of Clinical Pharmacy and Therapeutics Open access 10 May 2020 27
34 GABAA receptor‐mediated positive inotropism in guinea‐pig isolated left atria: evidence for the involvement of capsaicin‐sensitive nerves Carlo Alberto Maggi, Sandro Giuliani, Stefano Manzini et al. · British Journal of Pharmacology Open access May 1989 26
35 Varespladib methyl in cardiovascular disease Robert S. Rosenson, Heather I. Fraser, Joaquim Trias et al. · Expert Opinion on Investigational Drugs Sep 2010 22
36 Burden of Friedreich’s Ataxia to the Patients and Healthcare Systems in the United States and Canada Barbara Polek, Mary Jo Roach, William T. Andrews et al. · Frontiers in Pharmacology Open access 2013 21
37 Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia Matthias L. Jauslin, Silvia Vertuani, Elisa Durini et al. · Molecular and Cellular Biochemistry 2 May 2007 21
38 Effect of lorcaserin on glycemic parameters in patients with type 2 diabetes mellitus Faidon Magkos, Elena Nikonova, Randi Fain et al. · Obesity Open access 27 Mar 2017 18
39 Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials Sandesh C.S. Nagamani et al. · Molecular Genetics and Metabolism Open access 6 Aug 2015 18
40 Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome Robert S. Rosenson, Heather I. Fraser, Michael A. Goulder et al. · Cardiovascular Drugs and Therapy 11 Oct 2011 18
41 Do Trabecular Metal Acetabular Components Reduce the Risk of Rerevision After Revision THA Performed for Periprosthetic Joint Infection? A Study Using the NJR Data Set Gulraj S. Matharu, Andrew Judge, David W. Murray et al. · Clinical Orthopaedics and Related Research Open access 12 Nov 2018 17
42 Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser Morton Aaron Scheinberg, Colin Hislop, Renée S. Martin · Expert Opinion on Biological Therapy 7 Apr 2016 17
43 Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey Pangaja Paramsothy, Adrienne R. Herron, Molly M. Lamb et al. · PLoS Currents Open access 2018 15
44 Effects of lorcaserin on pre‐existing valvulopathy: A pooled analysis of phase 3 trials Neil J. Weissman, Steven R. Smith, Randi Fain et al. · Obesity Open access 26 Nov 2016 14
45 Carbohydrate Restriction Reduces Lipids and Inflammation and Prevents Atherosclerosis in Guinea Pigs Moises Torres‐Gonzalez, Jeff S. Volek, José Oyama Moura Leite et al. · Journal of Atherosclerosis and Thrombosis Open access 2008 12
46 RESUME-1: A Phase III Study of Tolperisone in the Treatment of Painful, Acute Muscle Spasms of the Back Sanam Ara Vaughan, Kayla Torres, Randall E. Kaye · Pain Management Open access Jul 2021 11
47 Predicting Response of Vitreous Hemorrhage after Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase) in Patients with Diabetes Abdhish R. Bhavsar, Lisa R. Grillone, Timothy R. McNamara et al. · Investigative Ophthalmology & Visual Science Oct 2008 11
48 Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565) Srinivas R. Nalamachu, Joseph V. Pergolizzi, Randall E. Kaye · Journal of Pain Research Open access Nov 2020 10
49 A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis Michael W. Konstan, Jeffrey S. Wagener, Michael A. Wilschanski et al. · Clinical Investigation Open access 2018 10
50 Role Attainment in Emerging Adulthood: Subjective Evaluation by Male Adolescents and Adults with Duchenne and Becker Muscular Dystrophy Holly Landrum Peay, Barbara T. Do, Neil M. Khosla et al. · Journal of Neuromuscular Diseases Open access 5 Mar 2022 8

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.